Trillium Therapeutics Inc

TTI has an industry-experienced scientific team with expertise in immunology, protein chemistry, assay development, molecular biology, recombinant protein production and process development. Internal research is conducted at the Company’s facility in Toronto, Canada, and is focused on protein production, in vitro mechanism of action studies and in vivo proof-of-principal studies in animal models. In addition to its corporate partnerships, the Company has an extensive network of academic collaborators at leading international research organizations, and has assembled a panel of key opinion leaders to guide the clinical development of the TTI-1612 program.